Bildkälla: Stockfoto

OssDsign Q4: Sales on point, but costs surprised - Redeye

Redeye sees a Q4 with sales coming in according to our estimates, but we note that costs came in higher than expected (both in COGS and OPEX: one-offs related to Cranial and other temporary).

Redeye sees a Q4 with sales coming in according to our estimates, but we note that costs came in higher than expected (both in COGS and OPEX: one-offs related to Cranial and other temporary).
Börsvärldens nyhetsbrev
ANNONSER